Clinical Trials
358
Active:2
Completed:255
Trial Phases
6 Phases
Early Phase 1:3
Phase 1:59
Phase 2:51
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (170 trials with phase data)• Click on a phase to view related trials
Phase 1
59 (34.7%)Phase 2
51 (30.0%)Not Applicable
25 (14.7%)Phase 4
22 (12.9%)Phase 3
10 (5.9%)Early Phase 1
3 (1.8%)Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
Phase 1
Recruiting
- Conditions
- Alcohol Use Disorder
- Interventions
- Drug: Intravenous Ethanol
- First Posted Date
- 2025-06-19
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 30
- Registration Number
- NCT07027839
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Phase 1
Recruiting
- Conditions
- Long COVIDPost Acute Sequelae of COVID-19
- Interventions
- Drug: 11C-PS13
- First Posted Date
- 2025-04-10
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 60
- Registration Number
- NCT06920628
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 30
- Registration Number
- NCT06795581
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers
Phase 1
Recruiting
- Conditions
- Healthy
- Interventions
- Drug: 11C-JMJ-129
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 40
- Registration Number
- NCT06874205
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety
Phase 2
Recruiting
- Conditions
- Psychiatric DisordersAnxiety Disorders
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 150
- Registration Number
- NCT06595953
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 72
- Next
News
No news found